期刊文献+

CD133 β-catenin和APC在结直肠癌组织中的表达及其与预后的关系 被引量:4

Expression and Prognostic Value of CD133,β-catenin,and APC Proteins in Colorectal Carcinoma Tissues
下载PDF
导出
摘要 目的:探讨CD133、β-catenin和APC蛋白在结直肠癌发生发展中的作用,分析三者的表达和临床病理特征与结直肠癌患者预后的关系。方法:应用组织芯片及免疫组织化学法检测74例结直肠腺瘤、135例结直肠癌及癌旁正常黏膜组织中CD133、β-catenin和APC蛋白的表达;结合随访资料进行单因素Kaplan-Meier生存分析及多因素Cox回归分析。结果:CD133在结直肠癌中阳性率为45.9%,高于腺瘤(9.5%)及癌旁正常黏膜(0,P<0.05),其表达与腺瘤不典型增生程度及结直肠癌组织分级具有相关性(P<0.05);β-catenin胞质/胞核阳性表达在结直肠癌(93.3%)和腺瘤(85.1%),高于癌旁正常黏膜(14.8%,P<0.05),β-catenin膜表达缺失率在结直肠癌(45.2%)高于腺瘤(4.1%)及癌旁正常黏膜(5.2%,P<0.05),且与淋巴结转移及Dukes分期有关(P<0.05);APC阳性表达率在癌旁正常黏膜(100%)、腺瘤(90.5%)和结直肠癌(34.8%)呈逐级降低(P<0.05),在结直肠癌APC表达缺失组,β-catenin胞质/胞核表达与CD133表达呈正相关(P<0.05)。单因素和多因素生存分析均筛选出Dukes分期、β-catenin膜表达缺失为影响结直肠癌患者预后的高风险因素及独立预后影响因素(P<0.05)。结论:CD133、β-catenin、APC参与了结直肠癌的发生发展,CD133表达与β-catenin及APC之间存在密切联系,三者的检测对结直肠癌的早期诊断、生物学行为及预后评估有一定意义。 Objective: The objectives of this study were to investigate the clinical significance ofCD133, β-catenin, and APC protein expression in the tumorigenesis and progression of colorectal carcinoma (CRC) as well as evaluate the relationship between the clinico- pathological characteristics of these proteins and prognosis in CRC patients. Methods: The expression levels of CD133, β-catenin, and APC were detected using immunohistochemistry SP (streptavidin peroxidase ) assay in tissue microarrays consisting of 135 specimens of CRC and adjacent normal mucosa (ANM) tissues and 74 specimens of colorectal adenoma (CRA) tissues. Clinical follow-up data and survival were assessed using Kaplan - Meier analysis and multivariate Cox regression. Results: The positive rates of CD 133 (45.9%) in CRC were significantly higher than those in CRA (9.5%) and ANM (0%) (P〈0.05), and they were related with the degree of dysplasia of CRA and the degree of differentiation of CRC (P〈0.05). The ectopic expression levels of β-catenin in the cytoplasrrdnucleus of CRC (93.3%) and CRA (85.1%) were higher than those in the cytoplasm/nucleus of ANM (14.8%) (P〈0.05). Loss of expression of β-catenin was significantly higher in the cytomembrane of CRC (45.2%) than in those of CRA (4.1%) and ANM (5.2%) (P〈0.05), and it was associated with lymph node metastasis and Dukes stage of CRC (P〈0.05). The positive rates of APC gradually decreased from 100.0% in ANM to 90.5% in CRA to 34.8% in CRC (P〈0.05). The expression of β-catenion in the cytoplasm/nucleus was positively correlated with CD 133 in CRC (P〈0.05), mainly appearing in the group lacking APC expression. Kaplan - Meier analysis and multivariate Cox regression demonstrated that Dukes stage and loss of expression of β-catenin in the cytomembrane were not only high-risk factors in the prognosis of CRC patients hut also independent prognostic factors for low survival in CRC (P〈0.05). Conclusions: CD133, β-catenin, and APC may play important roles in the tumorigenesis and progression of CRC. CD 133 and β-catenirdAPC have intrinsic relationships among them. Their detection may be of value in understanding the early diagnosis of CRC and in evaluating the biological behavior and prognosis of the disease.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2012年第23期1899-1903,共5页 Chinese Journal of Clinical Oncology
基金 广东省科技计划项目(编号:2009B080800023)资助~~
关键词 结直肠癌 CD133 Β-CATENIN APC 免疫组织化学 Colorectal carcinoma CD133 [β-catenin APC Immunohistochemistry
  • 相关文献

参考文献4

二级参考文献131

  • 1杨剑锋,陈森林,刘志红,张芸.乳腺癌组织中E-cadherin、β-catenin及cyclin D1表达的相关性研究[J].癌症,2004,23(7):799-802. 被引量:23
  • 2付志婕,潘新良,雷大鹏,刘大昱,刘文君,刘春喜,王荣,叶萍.细胞周期素D1和p16在下咽癌中的表达及临床意义[J].临床耳鼻咽喉头颈外科杂志,2007,21(9):406-409. 被引量:10
  • 3Nelson WJ, Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways [J]. Science, 2004,303 (5663):1483- 1487.
  • 4Doucas H, Garcea G, Neal CP, et al. Changes in the Wnt signaling pathway in gastrointestinal cancers and their prognostic significance [J]. Eur J Cancer, 2005,41 (3) :365- 379.
  • 5Su Y, Shrubsole MJ, Ness RM, et al. Immunohistochemical expressions of ki-67, Cyclin D1, beta-Catenin, cyclooxygenase-2 and epidermal growth factor receptorin human colorectal adenoma: a validation study of tissue microarrays [J]. Cancer Epidemiol Biomarkers Prey, 2006,15 (9) : 1719- 1727.
  • 6Wang Y, Liu S, Zhu H, et al. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma [J]. Int J Cancer, 2008, 123(3) :561-568.
  • 7Tsuehiya R, Yamamoto G, Nagoshi Y, et al. Expression of adenomatous polyposis coli in tumorigenesis of human oral squamous cell carcinoma [ J ]. Oral Oncol, 2004,40 (9) : 932-940.
  • 8Zlobec I, Lugli A, Baker K, et al. Role of APAF-1, et al. E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer [J]. J Pathol, 2007,212(3): 260-268.
  • 9Carson CC, 3rd. Carcinoma of the prostate: overview of the most common malignancy in men. N C MedJ 2006; 67:122- 127.
  • 10Shaw GL, Wilson P, Cuzick J, et al. International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients. BJU lnt 2007; 99:1056-1065.

共引文献77

同被引文献49

  • 1杨银学,魏军,张东,王立斌.APC基因与家族性腺瘤性息肉病[J].第四军医大学学报,2005,26(23):2202-2204. 被引量:2
  • 2陆以霞,赵丽萍,薛鸿鹏,卢艳红,迟宝荣.APC基因在胃癌、癌前病变及胃腺瘤中表达意义的研究[J].中国医师进修杂志(内科版),2007,30(6):11-13. 被引量:1
  • 3Salahshor S, Woodgett JR. The links between axin and carcinogenesis [ J . J Clin Pathol,2005 ,58 (3) :225-36.
  • 4Chun KS, Surh YJ. Signal transduction pathways regulating cyclooxygen-ase-2 expression: potential molecular targets for hemoprevention (J). Biochem Pharmaco1,2004 ,68 (6) : 1089-100.
  • 5El:Bassiouni A, Nosseir M, Zoheiry M, et al. Immunohistochemical ex- pression of CD95 (Fas) ,c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carci- noma [ J ]. APMIS, 2006 , 114 ( 6 ) :420 -7.
  • 6Gibbs CP,Kukekov VG,Reith JD. Stem-like cells in bone sarcomas:implications for tumorigenesis[J].{H}Neoplasia,2005,(11):967-976.
  • 7Zhang H,Wu H,Zheng J. Transforming growth factorβ1 sig-nal is crucial for dedifferentiation of cancer cells to cancer stem cells in osteosarcoma[J].{H}STEM CELLS,2013,(03):433-446.
  • 8Martins-Neves SR,Lopes áO,do Carmo A. Therapeutic im-plications of an enriched cancer stem-like cellpopulation in a hu-man osteosarcoma cellline[J].{H}BMC Cancer,2012.139.
  • 9Saini V,Hose CD,Monks A. Identification of CBX3 and AB-CA5 as Putative Biomarkers for Tumor Stem cells in Osteosarco-ma[J].PloS One,2012,(08):e41401.
  • 10Lisa Y,Pang mail,Emma L. Global Gene Expression Analy-sis of Canine Osteosarcoma Stem cells Reveals a Novel Role for COX-2 in Tumour Initiation[J].PloS One,2014,(01):e83144.

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部